VEBINOVE Trademark

Trademark Overview

On Tuesday, December 20, 2011, a trademark application was filed for VEBINOVE with the United States Patent and Trademark Office. The USPTO has given the VEBINOVE trademark a serial number of 85499493. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2015. This trademark is owned by Pfizer Inc.. The VEBINOVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
vebinove

General Information

Serial Number85499493
Word MarkVEBINOVE
Filing DateTuesday, December 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 10, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 10, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 12, 2015EXTENSION 5 GRANTED
Wednesday, December 17, 2014EXTENSION 5 FILED
Wednesday, December 17, 2014TEAS EXTENSION RECEIVED
Wednesday, July 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 15, 2014EXTENSION 4 GRANTED
Monday, July 7, 2014EXTENSION 4 FILED
Monday, July 7, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2013EXTENSION 3 GRANTED
Friday, December 13, 2013EXTENSION 3 FILED
Friday, December 13, 2013TEAS EXTENSION RECEIVED
Tuesday, July 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2013EXTENSION 2 GRANTED
Monday, June 10, 2013EXTENSION 2 FILED
Friday, July 5, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 10, 2013TEAS EXTENSION RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2012EXTENSION 1 GRANTED
Friday, December 14, 2012EXTENSION 1 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Friday, November 16, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 12, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 6, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 5, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, April 4, 2012ASSIGNED TO LIE
Wednesday, April 4, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 4, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, April 4, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 27, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 23, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

vebinove preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases